Sona Nanotech Inc. (SONA.CN)
CAD 0.28
(-3.51%)
CAD 0.28
(-3.51%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -2.01 Million CAD | 17.88% |
| 2022 | -2.33 Million CAD | 74.55% |
| 2021 | -10.38 Million CAD | -66.34% |
| 2020 | -6.23 Million CAD | -338.28% |
| 2019 | -1.41 Million CAD | 72.3% |
| 2018 | -5.13 Million CAD | -3033.06% |
| 2017 | -490.99 Thousand CAD | 66.37% |
| 2016 | -3.56 Million CAD | 11.93% |
| 2015 | -803.31 Thousand CAD | -22.41% |
| 2014 | -2.01 Million CAD | 27.25% |
| 2013 | -624.51 Thousand CAD | -117.88% |
| 2012 | -5.33 Million CAD | 501.9% |
| 2011 | -767.91 Thousand CAD | -17.34% |
| 2010 | -759.63 Thousand CAD | 9.75% |
| 2009 | -8.72 Million CAD | 67.07% |
| 2008 | -2.44 Million CAD | -138.68% |
| 2007 | -1.03 Million CAD | -309.58% |
| 2006 | -251.51 Thousand CAD | -6998.98% |
| 2005 | -3543.00 CAD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q3 | -524.34 Thousand CAD | 12.18% |
| 2024 Q2 | -595.04 Thousand CAD | -8.11% |
| 2024 Q1 | -561.9 Thousand CAD | 3.78% |
| 2023 Q2 | -437.32 Thousand CAD | -20.47% |
| 2023 Q1 | -363 Thousand CAD | -137.79% |
| 2023 FY | - CAD | 9.08% |
| 2023 Q4 | -753.66 Thousand CAD | -11.47% |
| 2023 Q3 | -676.08 Thousand CAD | -54.6% |
| 2022 Q4 | 960.58 Thousand CAD | 224.68% |
| 2022 FY | - CAD | 74.55% |
| 2022 Q1 | -1.49 Million CAD | -14.46% |
| 2022 Q2 | -1.31 Million CAD | 12.14% |
| 2022 Q3 | -770.41 Thousand CAD | 41.34% |
| 2021 Q1 | -3.71 Million CAD | -9.93% |
| 2021 Q2 | -3.12 Million CAD | 15.86% |
| 2021 Q3 | -2.14 Million CAD | 31.51% |
| 2021 FY | - CAD | -66.34% |
| 2021 Q4 | -1.3 Million CAD | 38.98% |
| 2020 Q3 | -1.7 Million CAD | -111.07% |
| 2020 Q4 | -3.37 Million CAD | -98.09% |
| 2020 Q2 | -808.13 Thousand CAD | -177.83% |
| 2020 Q1 | -290.87 Thousand CAD | 13.41% |
| 2020 FY | - CAD | -338.28% |
| 2019 Q2 | -388.6 Thousand CAD | -30.5% |
| 2019 FY | - CAD | 72.3% |
| 2019 Q1 | -297.77 Thousand CAD | 93.6% |
| 2019 Q3 | -388.56 Thousand CAD | 0.01% |
| 2019 Q4 | -335.92 Thousand CAD | 13.55% |
| 2018 Q3 | -146.14 Thousand CAD | 6.23% |
| 2018 Q1 | -129.29 Thousand CAD | -45.05% |
| 2018 FY | - CAD | -3033.06% |
| 2018 Q4 | -4.65 Million CAD | -3084.81% |
| 2018 Q2 | -155.86 Thousand CAD | -20.55% |
| 2017 Q2 | -81.45 Thousand CAD | 14.26% |
| 2017 FY | - CAD | 66.37% |
| 2017 Q4 | -89.14 Thousand CAD | -187.18% |
| 2017 Q3 | 102.25 Thousand CAD | 225.53% |
| 2017 Q1 | -95 Thousand CAD | 35.05% |
| 2016 Q2 | -120.35 Thousand CAD | 7.83% |
| 2016 FY | - CAD | 11.93% |
| 2016 Q3 | -87.06 Thousand CAD | 27.66% |
| 2016 Q4 | -146.26 Thousand CAD | -68.0% |
| 2016 Q1 | -130.58 Thousand CAD | 10.66% |
| 2015 Q3 | -140.15 Thousand CAD | -13.83% |
| 2015 Q2 | -123.12 Thousand CAD | 11.66% |
| 2015 Q1 | -139.37 Thousand CAD | 9.58% |
| 2015 FY | - CAD | -22.41% |
| 2015 Q4 | -146.15 Thousand CAD | -4.28% |
| 2014 Q4 | -154.13 Thousand CAD | -142.11% |
| 2014 Q3 | -63.66 Thousand CAD | 41.25% |
| 2014 Q2 | -108.36 Thousand CAD | 11.3% |
| 2014 FY | - CAD | 27.25% |
| 2014 Q1 | -122.17 Thousand CAD | 16.06% |
| 2013 Q3 | -143.86 Thousand CAD | 10.0% |
| 2013 FY | - CAD | -117.88% |
| 2013 Q2 | -159.84 Thousand CAD | -3.52% |
| 2013 Q4 | -145.54 Thousand CAD | -1.16% |
| 2013 Q1 | -154.4 Thousand CAD | 17.42% |
| 2012 Q1 | 4.12 Million CAD | 1948.62% |
| 2012 FY | - CAD | 501.9% |
| 2012 Q4 | -186.98 Thousand CAD | -13.6% |
| 2012 Q3 | -164.59 Thousand CAD | 55.74% |
| 2012 Q2 | -371.87 Thousand CAD | -109.02% |
| 2011 FY | - CAD | -17.34% |
| 2011 Q2 | -218.43 Thousand CAD | -6.17% |
| 2011 Q1 | -205.73 Thousand CAD | -23.85% |
| 2011 Q3 | -210.34 Thousand CAD | 3.7% |
| 2011 Q4 | -223.02 Thousand CAD | -6.03% |
| 2010 Q2 | 9053.00 CAD | 104.51% |
| 2010 Q1 | -200.84 Thousand CAD | -38.75% |
| 2010 Q4 | -166.1 Thousand CAD | -3.4% |
| 2010 Q3 | -160.65 Thousand CAD | -1874.55% |
| 2010 FY | - CAD | 9.75% |
| 2009 Q1 | -284.94 Thousand CAD | 53.49% |
| 2009 FY | - CAD | 67.07% |
| 2009 Q2 | -198.6 Thousand CAD | 30.3% |
| 2009 Q4 | -144.75 Thousand CAD | 20.23% |
| 2009 Q3 | -181.46 Thousand CAD | 8.63% |
| 2008 Q2 | -1.25 Million CAD | -1006.17% |
| 2008 Q4 | -612.6 Thousand CAD | -27.61% |
| 2008 Q3 | -480.04 Thousand CAD | 61.69% |
| 2008 FY | - CAD | -138.68% |
| 2008 Q1 | -113.28 Thousand CAD | 74.6% |
| 2007 Q4 | -445.99 Thousand CAD | -91.62% |
| 2007 Q3 | -232.75 Thousand CAD | -2.77% |
| 2007 Q2 | -226.48 Thousand CAD | -81.3% |
| 2007 Q1 | -124.92 Thousand CAD | -17.32% |
| 2007 FY | - CAD | -309.58% |
| 2006 FY | - CAD | -6998.98% |
| 2006 Q2 | -93.35 Thousand CAD | -217009.3% |
| 2006 Q4 | -106.47 Thousand CAD | -104.6% |
| 2006 Q3 | -52.04 Thousand CAD | 44.25% |
| 2006 Q1 | -43.00 CAD | 0.0% |
| 2005 FY | - CAD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| BioMark Diagnostics Inc. | -1.11 Million CAD | -81.189% |
| Izotropic Corporation | -1.6 Million CAD | -25.77% |